[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595170":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":27,"locations":33,"responsibleParty":111,"collaborators":10,"id":113,"slug":114,"hasResults":115,"nctId":116,"briefTitle":117,"officialTitle":117,"acronym":10,"eligibilityCriteria":118,"healthyVolunteers":115,"sex":119,"minAge":10,"maxAge":10,"enrollmentInfo":120,"targetDuration":123,"studyType":124,"phases":10,"briefSummary":125,"conditions":126,"keywords":128,"overallStatus":63,"whyStopped":10,"lastUpdateSubmitDate":131,"lastUpdatePostDateStruct":132,"startDateStruct":135,"completionDateStruct":137,"leadSponsor":139,"locationsCount":140},{"fullName":5,"class":6},"Nanjing IASO Biotechnology Co., Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"All patients received Equecabtagene Autoleucel Injection",null,[12],"Other: No Intervention (subjects were previously treated with Equecabtagene Autoleucel Injection) )",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"OTHER","No Intervention (subjects were previously treated with Equecabtagene Autoleucel Injection) )","This study is observational study and all participants will be obsreved with no intervention.",[9],[20,24],{"name":21,"affiliation":22,"role":23},"Jian Li, PhD","Peking Union Medical College Hospital","PRINCIPAL_INVESTIGATOR",{"name":25,"affiliation":26,"role":23},"Juan Du, PhD","RenJi Hospital",[28],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},"Wen Ye","CONTACT","+86 025-58287610","wen.ye@iasobio.com",[34,51,61,75,85,98],{"facility":35,"status":36,"city":37,"state":10,"zip":10,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Peking University First Hospital","NOT_YET_RECRUITING","Beijing","China","CN",{"type":41,"coordinates":42},"Point",[43,44],116.39723,39.9075,{"lat":44,"lon":43},[47],{"name":48,"role":30,"phone":49,"phoneExt":10,"email":50},"Yujun Dong","+86 18210264969","dongy@hsc.pku.edu.cn",{"facility":52,"status":36,"city":37,"state":10,"zip":10,"country":38,"countryCode":39,"cosmosGeoPoint":53,"geoPoint":55,"contacts":56},"People's Hospital of Peking Universit",{"type":41,"coordinates":54},[43,44],{"lat":44,"lon":43},[57],{"name":58,"role":30,"phone":59,"phoneExt":10,"email":60},"Jin Lu","+86 13311491805","jin1lu@sina.com",{"facility":62,"status":63,"city":64,"state":10,"zip":10,"country":38,"countryCode":39,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences","RECRUITING","Tianjin",{"type":41,"coordinates":66},[67,68],117.17667,39.14222,{"lat":68,"lon":67},[71],{"name":72,"role":30,"phone":73,"phoneExt":10,"email":74},"Dehui Zou","+86 13602100955","zoudehui@ihcams.ac.cn",{"facility":76,"status":63,"city":64,"state":10,"zip":10,"country":38,"countryCode":39,"cosmosGeoPoint":77,"geoPoint":79,"contacts":80},"Tianjin Medical University General Hospital",{"type":41,"coordinates":78},[67,68],{"lat":68,"lon":67},[81],{"name":82,"role":30,"phone":83,"phoneExt":10,"email":84},"Rong Fu","+86 13920350233","furong8369@tmu.edu.cn",{"facility":86,"status":36,"city":87,"state":10,"zip":10,"country":38,"countryCode":39,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology","Wuhan",{"type":41,"coordinates":89},[90,91],114.26667,30.58333,{"lat":91,"lon":90},[94],{"name":95,"role":30,"phone":96,"phoneExt":10,"email":97},"Chunrui Li","+86 13647233185","cunrui5650@126.com",{"facility":99,"status":36,"city":100,"state":10,"zip":10,"country":38,"countryCode":39,"cosmosGeoPoint":101,"geoPoint":105,"contacts":106},"Henan Cancer Hospital Affilated Cancer Hospital of Zhengzhou University","Zhengzhou",{"type":41,"coordinates":102},[103,104],113.64861,34.75778,{"lat":104,"lon":103},[107],{"name":108,"role":30,"phone":109,"phoneExt":10,"email":110},"Baijun Fang","+86 13526607830","fdation@126.com",{"type":112,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100595170","long-term-follow-up-registry-study-of-equecabtagene-autoleucel-injection-100595170",false,"NCT07028970","Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection","Inclusion Criteria:\n\n\\- 1.Received Equecabtagene Autoleucel Injection treatment; 2.For those who participated in pre-marketing clinical studies or post-marketing real-world studies, must have completed or withdrawn from the original study; 3.Voluntary signing of an informed consent form approved by the ethics committee.\n\nExclusion Criteria:\n\n* 1\\. Receipt of another lentiviral vector-based cell or gene therapy (either commercialized product or investigational product in a clinical tiral) between the infution of Equecabtagene Autoleucel Injection and the signing informed consent.","ALL",{"count":121,"type":122},1500,"ESTIMATED","15 Years","OBSERVATIONAL","This is a multicenter, open-label, single-arm, long-term follow-up clinical study. All patients who have received Equecabtagene Autoleucel Injection treatment will be enrolled.",[127],"Multiple Myeloma",[129,130],"Long term follow up;","Eque-cel","2025-06-11",{"date":133,"type":134},"2025-06-19","ACTUAL",{"date":136,"type":134},"2024-12-15",{"date":138,"type":122},"2043-12",{"name":5,"class":6},6]